Basepoint Wealth’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.4K Sell
247
-88
-26% -$7.1K 0.01% 333
2026
Q1
$29K Buy
335
+3
+0.9% +$287 0.02% 277
2025
Q4
$31.9K Buy
+332
New +$32.2K 0.02% 257

Other funds holding MDT

Basepoint Wealth's MDT Position: Q2 2026 in Review

Basepoint Wealth reduced its Medtronic (MDT) stake by 26% in Q2 2026, selling an estimated $7.1K and leaving 247 shares worth $19.4K. The position accounts for 0.01% of the portfolio, ranked #333.

Basepoint Wealth first reported a position in MDT in Q4 2025 and has held it in 3 quarters since. The position peaked at $31.9K in Q4 2025. 2,137 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Basepoint Wealth held 247 shares of Medtronic worth $19.4K as of Q2 2026.
  • Basepoint Wealth sold 88 Medtronic shares in Q2 2026, an estimated $7.1K.
  • Medtronic made up 0.01% of Basepoint Wealth's portfolio in Q2 2026, its #333 holding.
  • Basepoint Wealth first reported a position in Medtronic in Q4 2025 and has held it in 3 quarters since.
  • Basepoint Wealth's Medtronic position peaked at $31.9K in Q4 2025.
  • 2,137 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Basepoint Wealth's 13F filing for Q2 2026, filed 10 Aug 2026.